Revelation Biosciences Correlations
REVB Stock | USD 0.76 0.01 0.67% |
The current 90-days correlation between Revelation Biosciences and Bright Minds Biosciences is -0.01 (i.e., Good diversification). The correlation of Revelation Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Revelation Biosciences Correlation With Market
Modest diversification
The correlation between Revelation Biosciences and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Revelation |
Moving together with Revelation Stock
0.66 | INKT | Mink Therapeutics | PairCorr |
0.61 | MREO | Mereo BioPharma Group | PairCorr |
0.75 | ACRV | Acrivon Therapeutics, | PairCorr |
0.67 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.77 | AFMD | Affimed NV | PairCorr |
0.64 | BDTX | Black Diamond Therap | PairCorr |
Moving against Revelation Stock
0.61 | MNOV | MediciNova | PairCorr |
0.38 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.36 | OPT | Opthea | PairCorr |
0.39 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.34 | ABEO | Abeona Therapeutics | PairCorr |
0.31 | ACIU | AC Immune | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Revelation Stock performing well and Revelation Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Revelation Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DRUG | 49.12 | 28.18 | 2.88 | (0.77) | 4.62 | 9.23 | 1,471 | |||
HPQ | 1.31 | 0.03 | 0.02 | 0.15 | 1.62 | 2.22 | 6.13 | |||
INTC | 2.36 | 0.04 | 0.07 | 0.14 | 2.58 | 6.36 | 18.29 | |||
CVX | 0.90 | 0.07 | 0.02 | 0.22 | 1.05 | 2.21 | 5.13 | |||
KO | 0.68 | (0.15) | 0.00 | (1.28) | 0.00 | 1.11 | 4.00 | |||
TRV | 1.08 | 0.15 | 0.11 | 0.27 | 1.17 | 1.93 | 11.31 | |||
JNJ | 0.61 | (0.10) | 0.00 | (0.37) | 0.00 | 1.40 | 3.25 | |||
JPM | 1.12 | (0.01) | 0.06 | 0.12 | 1.42 | 2.05 | 15.87 | |||
MSFT | 0.90 | (0.03) | (0.04) | 0.07 | 1.49 | 2.09 | 8.19 |
Revelation Biosciences Corporate Management
James Rolke | CEO Director | Profile | |
Carol Odle | Director Projects | Profile | |
Chester III | Chief Officer | Profile | |
Sandra Vedrick | Vice Relations | Profile |